Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 3 studies | 18% ± 2% |
Insufficient scRNA-seq data for expression of CACNG6 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 44% | 23.13 | 1162 / 2642 | 82% | 3.50 | 579 / 705 |
muscle | 100% | 3023.59 | 803 / 803 | 0% | 0 | 0 / 0 |
lung | 57% | 145.88 | 331 / 578 | 26% | 1.85 | 299 / 1155 |
pancreas | 0% | 0 | 0 / 328 | 39% | 3.52 | 70 / 178 |
peripheral blood | 27% | 21.19 | 255 / 929 | 0% | 0 | 0 / 0 |
uterus | 9% | 17.76 | 16 / 170 | 16% | 4.18 | 73 / 459 |
breast | 5% | 2.55 | 22 / 459 | 18% | 3.61 | 199 / 1118 |
ovary | 0% | 0 | 0 / 180 | 21% | 1.39 | 91 / 430 |
stomach | 11% | 3.02 | 39 / 359 | 8% | 0.53 | 22 / 286 |
prostate | 11% | 10.72 | 26 / 245 | 7% | 0.28 | 37 / 502 |
tonsil | 0% | 0 | 0 / 0 | 13% | 0.58 | 6 / 45 |
esophagus | 1% | 0.97 | 20 / 1445 | 8% | 0.72 | 15 / 183 |
intestine | 2% | 0.76 | 22 / 966 | 7% | 0.50 | 36 / 527 |
skin | 5% | 3.10 | 89 / 1809 | 2% | 0.06 | 10 / 472 |
bladder | 0% | 0 | 0 / 21 | 5% | 0.44 | 27 / 504 |
blood vessel | 3% | 2.33 | 44 / 1335 | 0% | 0 | 0 / 0 |
kidney | 0% | 0 | 0 / 89 | 3% | 0.26 | 27 / 901 |
adipose | 3% | 1.09 | 36 / 1204 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 3% | 0.34 | 12 / 406 |
thymus | 2% | 1.51 | 14 / 653 | 1% | 0.03 | 4 / 605 |
spleen | 2% | 0.65 | 5 / 241 | 0% | 0 | 0 / 0 |
adrenal gland | 0% | 0 | 0 / 258 | 1% | 0.18 | 3 / 230 |
heart | 0% | 0.11 | 2 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1902514 | Biological process | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel |
GO_0006816 | Biological process | calcium ion transport |
GO_0070588 | Biological process | calcium ion transmembrane transport |
GO_0005891 | Cellular component | voltage-gated calcium channel complex |
GO_0005886 | Cellular component | plasma membrane |
GO_1990454 | Cellular component | L-type voltage-gated calcium channel complex |
GO_0005246 | Molecular function | calcium channel regulator activity |
GO_0005245 | Molecular function | voltage-gated calcium channel activity |
Gene name | CACNG6 |
Protein name | Calcium channel, voltage-dependent, gamma subunit 6, isoform CRA_c (Calcium voltage-gated channel auxiliary subunit gamma 6) Voltage-dependent calcium channel gamma-6 subunit Voltage-dependent calcium channel gamma-6 subunit (Neuronal voltage-gated calcium channel gamma-6 subunit) |
Synonyms | hCG_1648888 |
Description | FUNCTION: Regulates the activity of L-type calcium channels that contain CACNA1C as pore-forming subunit. . FUNCTION: Regulates the activity of L-type calcium channels that contain CACNA1C as pore-forming subunit. . |
Accessions | A6NP74 Q9BXT2 A6NFR2 ENST00000352529.1 ENST00000252729.7 ENST00000346968.2 |